Tobias Bald

13PUBLICATIONS
78CO-AUTHORS
Biomolecular modelling and designMolecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Infectious agents
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 20, 2026
AI-enabled discovery and biochemical optimization of minibinders targeting cancer cell-surface proteins.

|Jan 04, 2024
Adipocyte Precursor-Derived NRG1 Promotes Resistance to FGFR Inhibition in Urothelial Carcinoma.

Sana Hosni, Viola Kilian, Niklas Klümper

|Nov 10, 2023
Pretreatment albumin is a prognostic and predictive biomarker for response to atezolizumab across solid tumors.

Jonas Saal, Jörg Ellinger, Manuel Ritter

|May 25, 2023
Stressed out: NKp46 binds ecto-calreticulin.

Dillon Corvino, Denise Rommel, Franziska Schneppenheim

|Feb 14, 2023
Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy.

Andrew O Yam, Jacqueline Bailey, Francis Lin

|Jun 08, 2022
IFN-λ Diminishes the Severity of Viral Bronchiolitis in Neonatal Mice by Limiting NADPH Oxidase-Induced PAD4-Independent NETosis.

Ismail Sebina, Ridwan B Rashid, Md Al Amin Sikder

Pageof 3

Frequent Collaborators

4 joint publications

Mark J Smyth

4 joint publications

Dillon Corvino

3 joint publications

Kyohei Nakamura

3 joint publications

Christian R Engwerda